Loading insider details...
Beta
Latest Form 4 (Oct 14, 2026): Exercise/Conversion of 23,191 INKT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | MiNK Therapeutics, Inc. (INKT) | Exercise/Conversion | 23,191 | n/a |
| Aug 7, 2026 | AGENUS INC (AGEN) | Grant/Award | 200,000 | n/a |
| Apr 28, 2026 | AGENUS INC (AGEN) | Grant/Award | 300,000 | n/a |
| Jan 6, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 31,474 | $350.0K |
| Sep 11, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 18,229 | $280.0K |
| May 6, 2025 | AGENUS INC (AGEN) | Grant/Award | 581 | $1.8K |
| May 5, 2025 | AGENUS INC (AGEN) | Grant/Award | 869 | $1.8K |
| Apr 10, 2025 | AGENUS INC (AGEN) | Grant/Award | 1,159 | $1.8K |
| Mar 27, 2025 | AGENUS INC (AGEN) | Grant/Award | 1,123 | $1.8K |
| Mar 24, 2025 | AGENUS INC (AGEN) | Grant/Award | 409 | $961.15 |